3billion tries to improve diagnostic accuracy and yield of rare disease genetic testing.

To achieve the goal, 3billion focuses on advancing genome interpretation technology by bioinformatics and machine learning.

3billion also develops technology for rare disease drug discovery. Based on big genome data and AI technology, 3billion focuses on developing methods for novel drug target discovery, drug candidate generation and safety assessment.